Ontology highlight
ABSTRACT: Purpose
Brain metastases (BM) themselves and treatment with stereotactic radiosurgery (SRS) can influence neurocognitive functioning. This prospective study aimed to assess neurocognitive decline in patients with BM after SRS.Methods
A neuropsychological test battery was assessed yielding ten test outcomes. Neurocognitive decline at 3 and 6 months post SRS was compared to measurement prior to Gamma Knife (GK) or linear accelerator (LINAC) SRS. Reliable change indices with correction for practice effects were calculated to determine the percentage of neurocognitive decline (defined as decline on ≥ 2 test outcomes). Risk factors of neurocognitive decline were analyzed with binary logistic regression.Results
Of 194 patients pre-SRS, 40 GK and 29 LINAC patients had data
SUBMITTER: Albers EAC
PROVIDER: S-EPMC9713121 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature